Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide crossover study of bone, testosterone, and glucose metabolism in men with primary osteoporosis
NL-OMON41473Recruiting
- Sponsor
- Academic Medical Center
- Start
- Feb 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of teriparatide in osteoporosis (2 arms), sponsored by Academic Medical Center. Primary endpoints: Undercarboxylated osteocalcin, Testosterone concentrations and 2 more. Started Feb 2013; status: recruiting.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NL-OMON41473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41473.